Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Moxonidine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Moxonidine 200microgram tablets
0205020M0AAAAAA
|
Moxonidine | Moxonidine | Cardiovascular System | 43,591 |
|
Moxonidine 400microgram tablets
0205020M0AAABAB
|
Moxonidine | Moxonidine | Cardiovascular System | 20,502 |
|
Moxonidine 300microgram tablets
0205020M0AAACAC
|
Moxonidine | Moxonidine | Cardiovascular System | 18,591 |
|
Physiotens 200microgram tablets (Mylan)
0205020M0BBAAAA
|
Physiotens | Moxonidine | Cardiovascular System | 693 |
|
Physiotens 400microgram tablets (Mylan)
0205020M0BBABAB
|
Physiotens | Moxonidine | Cardiovascular System | 233 |
|
Physiotens 300microgram tablets (Mylan)
0205020M0BBACAC
|
Physiotens | Moxonidine | Cardiovascular System | 163 |
|
Physiotens 200microgram tablets (Actavis)
0205020M0BBADAA
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 300microgram tablets (Actavis)
0205020M0BBAFAC
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 400microgram tablets (Actavis)
0205020M0BBAEAB
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.